Published online before print
February 5, 2009, 10.1183/09031936.00153408
Eur Respir J 2009; 33:1374-1382
Copyright ©ERS Journals Ltd 2009
Interferon- release assays do not identify more children with active tuberculosis than the tuberculin skin test
B. Kampmann,
E. Whittaker,
A. Williams,
S. Walters,
A. Gordon,
N. Martinez-Alier,
B. Williams,
A. M. Crook,
A-M. Hutton and
S. T. Anderson
For affiliations, please see the Acknowledgements section.
CORRESPONDENCE: B. Kampmann, Academic Dept of Paediatrics, 2nd Floor Wright-Fleming Building, Imperial College London, St. Mary's Campus, Norfolk Place, London W2 1PG, UK. Fax: 44 2075943894. E-mail: b.kampmann{at}imperial.ac.uk
Keywords: Children, interferon- release assays, skin test, tuberculosis
Received: October 10, 2008
Accepted January 12, 2009
Data are lacking on the performance of interferon- release assays (IGRAs) in children. Although IGRAs are recommended for screening for latent tuberculosis infection (LTBI), many clinicians wish to employ them as a diagnostic test for active tuberculosis (TB). The objective of the present study was to compare the performance of the two commercially available IGRAs and the tuberculin skin test (TST) side-by-side in children with active TB and LTBI.
In a prospective study, 209 children were investigated for active (n = 91) or latent TB (n = 118). TST, QuantiFERON-TB Gold In-tube (QFG-IT; Cellestis, Carnegie, Australia) and T-SPOT.TB (Oxford Immunotec, Abingdon, UK) assays were simultaneously used.
For culture-confirmed active TB, the sensitivity of the TST was 83%, compared with 80% for QFG-IT and 58% for T-SPOT.TB. IGRAs did not perform significantly better than TST, although QFG-IT was significantly better than T-SPOT.TB. The agreement between QFG-IT and T-SPOT.TB in culture-confirmed TB was poor at 66.7%. In LTBI, the agreement between QFG-IT and T-SPOT.TB was very good (92%) with moderate agreement between TST and T-SPOT.TB (75%) and QFG-IT and TST (77%).
A negative interferon- release assay should not dissuade paediatricians from diagnosing and treating presumed active tuberculosis. If used for diagnosis of latent tuberculosis infection, interferon- release assays could significantly reduce the numbers of children receiving chemoprophylaxis. Very good concordance between both tests was found.
This article has been cited by other articles:

|
 |

|
 |
 
C. Lange, M. Ernst, U. Greinert, C. Jafari, B. Kalsdorf, A. Strassburg, A. Bossink, S. Thijsen, J. A. D. Benitez, I. Latorre, et al.
Quantitative Pulmonary T-Cell Responses for the Diagnosis of Active Tuberculosis
Am. J. Respir. Crit. Care Med.,
February 1, 2010;
181(3):
289 - 290.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kumar, K. Nath, B. Rath, M. K. Sen, P. Vishalakshi, D. S. Chauhan, V. M. Katoch, S. Singh, S. Tyagi, V. Sreenivas, et al.
Visual Format for Detection of Mycobacterium tuberculosis and M. bovis in Clinical Samples Using Molecular Beacons
J. Mol. Diagn.,
September 1, 2009;
11(5):
430 - 438.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2009 by the European Respiratory Society.
|
|